fda glp-1 compounding warning letters october 2025 CDER Jump 50% in FY — What That Means for Industry FDA Issues Warnings to 30

For some, they feel like a breakthrough after years of struggling with blood sugar issues, metabolic dysfunction, or weight gain despite dieting and other approaches

This makes it excellent for surface wrinkles, fine lines, and skin quality improvements but limits its reach to deeper structures

Glucagon-Like Peptide 1 Receptor Agonists and Coronary Events Composite Outcomes Including Coronary Events Coronary events form a part of cardiovascular composite outcomes, such as cardiovascular mortality and major adverse cardiovascular events (MACE)

The awards honor organizations that demonstrate exceptional workplace culture based on direct employee feedback